Paper - WANFANG MED ONLINE

You Position: Home > Paper

聚己内酯在生物医学领域的应用研究进展

( views:222, downloads:4 )

Author:: No author available

Journal Title:: CHINESE JOURNAL OF BIOMEDICAL ENGINEERING

Issue:: 2

DOI:: 10.3760/cma.j.issn.1674-1927.2008.02.020

Key Word:: No keyword available

Abstract： @@ 生物材料是指对生物体进行诊断、治疗和置换损伤组织、器官或增进其功能的材料[1].到目前为止,生物材料经历了由生物惰性材料逐渐转向生物活性及可控降解吸收性材料的发展阶段,一些具有生物可降解性高分子材料,如聚酯类等产品逐渐被广泛应用于生物医学各领域.

Reference

[1]李靖扬,艾合麦提·玉素甫,陈平波,等.PCL膜对同种异体肌腱移植后粘连预防作用的实验研究[J].2005,(10).
[2]李俊杰,姚康德.组织工程用生物材料[J].2007,(2).
[3]陈建海,黄春霞,陈志良.聚己内酯材料的生物相容性与毒理学研究[J].2000,(4).
[4]黄争鸣,杨爱昭.将源药包覆到聚己内酯超细纤维的芯部[J].2006,(1).
[5]艾合麦提·玉素甫,陈统一,陈中伟.可降解聚已内酯材料的体外生物学特征：安全性评价[J].2004,(26).
[6]贾骏,段嫄嫄,周建学,等.聚己内酯电纺纤维的制备及生物相容性研究[J].2007,(5).
[7]Tanom, Bunaprasert,Narawut, Thongmarongsri,Voranut, Thanakit,etc.Tissue engineering of cartilage with porous polycarprolactone--alginate scaffold: the first report of tissue engineering in Thailand.[J].2006,89 Suppl 3.
[8]Nurcombe V,Luong-Van E,Cool S,etc.In vitro biocompatibility and bioactivity of microencapsulated heparan sulfate.[J].2007,28(12).
[9]Dietmar W. Hutmacher,Thorsten Schantz,Iwan Zein.Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling[J].2001,55(2).
[10]Jones DS,Djokic J,McCoy CP,etc.Poly(epsilon-caprolactone) and poly(epsilon-caprolactone)-polyvinylpyrrolidone-iodine blends as ureteral biomaterials: characterisation of mechanical and surface properties, degradation and resistance to encrustation in vitro.[J].2002,23(23).
[11]Ferreira P,Coelho JF,Gil MH.Development of a new photocrosslinkable biodegradable bioadhesive.[J].2008,352(1/2).
[12]Kim HW,Jun IK,Lee EJ,etc.Degradation and drug release of phosphate glass/polycaprolactone biological composites for hard-tissue regeneration.[J].2005,75(1).
[13]Shaofeng Zhang,Wei Yan,Jun Jia,etc.Preparation of collagen-coated electrospun nanofibers by remote plasma treatment and their biological properties[J].2007,18(9).
[14]Hutmacher DW,Too HP,Ng KW,etc.Evaluation of ultra-thin poly(epsilon-caprolactone) films for tissue-engineered skin.[J].2001,7(4).
[15]Swieszkowski W,Hutmacher DW,Kurzydlowski KJ,etc.Repair and regeneration of osteochondral defects in the articular joints.[J].2007,24(5).
[16]Remsberg CM,Yanez JA,Kwon GS,etc.Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity.[J].2008,25(1).
[17]Shenoy DB,D'Souza RJ,Tiwari SB,etc.Potential applications of polymeric microsphere suspension as subcutaneous depot for insulin.[J].2003,29(5).
[18]Chong EJ,Phan TT,Lim IJ,etc.Evaluation of electrospun PCL/gelatin nanofibrous scaffold for wound healing and layered dermal reconstitution.[J].2007,3(3).
[19]Lim TC,Moochhala S,Ng KW,etc.In vivo evaluation of an ultra-thin polycaprolactone film as a wound dressing[J].2007,18(7).
[20]Bridget, Rutledge,David, Huyette,Delbert, Day,etc.Treatment of osteomyelitis with local antibiotics delivered via bioabsorbable polymer.[J].2003,(411).